Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2010
05/14/2010WO2010012476A3 Genetic variations associated with feather pecking behaviour in avians
05/14/2010WO2010011283A3 Fus/tls-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases
05/14/2010WO2010007531A3 Use of defensin alpha 1 and/or defensin alpha 4, as a marker for predicting treatment response and/or a relapse in a patient suffering from chronic myeloid leukaemia
05/14/2010WO2010006072A3 Mtor modulators and uses thereof
05/14/2010WO2010003153A3 Methylation analysis of mate pairs
05/14/2010WO2010002852A3 Bead array reader based-hemagglutination and hemagglutination inhibition assays
05/14/2010WO2009158521A3 Blood transcriptional signature of mycobacterium tuberculosis infection
05/14/2010WO2009148995A8 Compositions for use in identification of adventitious viruses
05/14/2010WO2009143035A3 Methods and compositions for diagnosing and treating cervical intraepithelial neoplasia and cervical cancer
05/14/2010WO2009033140A9 Microrna signatures in human ovarian cancer
05/14/2010CA2743020A1 Test for predicting neutralization of asparaginase activity
05/14/2010CA2742917A1 Diagnostic transcript and splice patterns of hpv16 in different cervical lesions
05/14/2010CA2742737A1 Use of eef1a as biomarker and a method for screening metap2 inhibitors
05/14/2010CA2742726A1 Means and methods for investigating nucleic acid sequences
05/14/2010CA2742712A1 Methods and systems for treating and controlling oral periopathogens
05/14/2010CA2742600A1 Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta
05/14/2010CA2742598A1 Nucleic acid extraction on curved glass surfaces
05/14/2010CA2742583A1 Stem cell aggregate suspension compositions and methods for differentiation thereof
05/14/2010CA2742512A1 Method for optimizing the treatment of chronic myeloid leukemia with abl tyrosine kinase inhibitors
05/14/2010CA2742460A1 Systems and methods for enhanced scoda
05/14/2010CA2742380A1 Methods of monitoring conditions by sequence analysis
05/14/2010CA2741996A1 Sequence preserved dna conversion
05/14/2010CA2741906A1 Methods of using biomarkers
05/14/2010CA2741630A1 Suppression of secondary capture in microarray assays
05/14/2010CA2740242A1 Genetic polymorphisms in age-related macular degeneration
05/13/2010US20100122382 Cell Cycle Genes and Related Methods
05/13/2010US20100122372 Genetic loci associated with iron deficiency tolerance in soybean
05/13/2010US20100122370 Genetic loci associated with cell wall digestibility in maize
05/13/2010US20100122361 Humanisation of animals
05/13/2010US20100122354 Cdc6s as modifiers of the pten/akt pathway and methods of use
05/13/2010US20100122074 Blood Glucose Tracking Apparatus and Methods
05/13/2010US20100121582 Methods for accurate sequence data and modified base position determination
05/13/2010US20100121490 Base sequence detection apparatus and base sequence automatic analyzing apparatus
05/13/2010US20100121255 Compound
05/13/2010US20100121210 Method and device for detection ofanalyte in vapor or gaseous sample
05/13/2010US20100121166 Subcutaneous Glucose Electrode
05/13/2010US20100121165 Subcutaneous Glucose Electrode
05/13/2010US20100121135 Sperm cell separation methods and compositions
05/13/2010US20100121107 Crystal structure of bifunctional transglycosylase pbp1b from e. coli and inhibitors thereof
05/13/2010US20100120900 Methods And Sequences To Preferentially Suppress Expression of Mutated Huntingtin
05/13/2010US20100120899 Tumor Repressor Genes in the Prevention of Cancer
05/13/2010US20100120898 MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma
05/13/2010US20100120894 Intracellular DNA receptor
05/13/2010US20100120789 Compound
05/13/2010US20100120788 Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in prostate cells
05/13/2010US20100120787 Modification of amyloid-beta load in non-brain tissue
05/13/2010US20100120700 Methods and compositions for treating cervical cancer
05/13/2010US20100120632 Methods and Compositions For Sorting and/or Determining Organisms
05/13/2010US20100120631 Methods for detecting hepatocellular carcinoma
05/13/2010US20100120629 Biomarkers for Differentiating Between Type 1 and Type 2 Diabetes
05/13/2010US20100120628 Genemap of the human genes associated with adhd
05/13/2010US20100120627 Genemap of the human genes associated with psoriasis
05/13/2010US20100120625 Methods for detecting modification resistant nucleic acids
05/13/2010US20100120624 Assessment of oocyte competence
05/13/2010US20100120151 enables embryogenic tissue to be detected in vitro thus allows for early discading of non-embryonic tissue; antioxidant; inhibition or retardation of apoptotic processes; tablet or cream form as an antiaging agent; used in generating male sterile plants
05/13/2010US20100120086 Medium for detecting and differentiating vancomycin-resistant enterococci
05/13/2010US20100120085 Method for separation, characterization and/or identification of microorganisms using mass spectrometry
05/13/2010US20100120084 Reaction medium for identifying/detecting microorganisms
05/13/2010US20100120083 Disposable cassette and method of use for blood analysis on blood analyzer
05/13/2010US20100120082 Optimization of Process Variables in Oxygen Enriched Fermentors Through Process Controls
05/13/2010US20100120081 High sensitivity parameters for the detection of vitamin b12 and/or folate deficiencies and methods of use
05/13/2010US20100120080 Cancer diagnosis using ki-67
05/13/2010US20100120079 Trans-Differentiation And Re-Differentiation Of Somatic Cells And Production Of Cells For Cell Therapies
05/13/2010US20100120078 Urine Stabilization System
05/13/2010US20100120077 Microfluidic particle-analysis systems
05/13/2010US20100120076 Method for antenatal estimation of risk of aneuploidy
05/13/2010US20100120075 Composition and a method for suppressing the luminescence intensity decline in a luciferin-luciferase reaction
05/13/2010US20100120062 Rhizome viability determination method
05/13/2010US20100120053 Tissue analysis and kits therefor
05/13/2010US20100120052 Orotate Transporter Encoding Marker Genes
05/13/2010US20100120051 Have negatively charged substituent for fluorescent staining of DNA; used to distinguish DNA present in a sample from RNA
05/13/2010US20100120050 Biomarkers For Assessing Altherosclerotic Potential
05/13/2010US20100120049 Biomarkers for serious skin rash
05/13/2010US20100120048 Assays for short sequence variants
05/13/2010US20100120047 Purification of target cells from complex biological fluids
05/13/2010US20100120046 Genetic Markers for Assessing Risk of Developing Bipolar Disorder
05/13/2010US20100120045 Genetic variants useful for risk assessments of coronary artery disease and myocardial infarction
05/13/2010US20100120044 Modified polynucleotides comprising ribose rings
05/13/2010US20100120043 Sequential analysis of biological samples
05/13/2010US20100120042 Method of screening material for improving skin functions
05/13/2010US20100120041 Methods for detecting and treating kidney disease
05/13/2010US20100120040 Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
05/13/2010US20100120039 Methods and compositions in breast cancer therapy resistance
05/13/2010US20100120038 Assay methods for increased throughput of samples and/or targets
05/13/2010US20100120037 Method for isolating and culturing unculturable microorganisms
05/13/2010US20100120036 Method for amplifying dna fragment
05/13/2010US20100120035 Method for accurate assessment of dna quality after bisulfite treatment
05/13/2010US20100120034 Methylation analysis of mate pairs
05/13/2010US20100120033 Method for measuring dna methylation
05/13/2010US20100120032 Transgenic plant event detection
05/13/2010US20100120031 Synthesis of trans-tert-butyl-2-aminocyclopentylcarbamate
05/13/2010US20100120030 Extracellular serine protease
05/13/2010US20100120029 Mutagenesis of aspergillus fungi and genes essential for growth
05/13/2010US20100120028 Probe, probe set, probe-immobilized carrier, and genetic testing method
05/13/2010US20100120027 Prognostic test for early stage non small cell lung cancer (nsclc)
05/13/2010US20100120026 Particulate Substrates for Improved Recovery of Microbes
05/13/2010US20100120025 Compositions and Methods for Prognosis, Diagnosis, Prevention and Treatment of Cancers
05/13/2010US20100120024 Materials and methods for the generation of transcripts comprising modified nucleotides
05/13/2010US20100120023 Detection of macromolecular complexes with harmonic cantilevers
05/13/2010US20100120022 useful as diagnostic markers of a variant-detectable disease; Nucleic Acid Testing; more sensitive and specific; sequence specific rather than epitope specific
1 ... 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 ... 3003